{"transactions":[{"id":1761884,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":109067,"kind":"person","name":"Powchik Peter","position":1,"cik":"0001377247","reported_name":"Powchik Peter","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2023-10-11T21:42:02.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":159744,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These options were granted following the Reporting Person joining the Issuer's leadership team as Executive Vice President, Global Scientific Director, effective October 1, 2023, while remaining a member of the Issuer's board of directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vest in 12 equal monthly installments beginning on October 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These stock options shall expire upon the earlier of (i) the tenth anniversary of the grant date, and (ii) three months after the date the Reporting Person ceases to be a director, officer, employee or consultant of the Issuer or one of its affiliates."}],"balance_after":159744,"derivative":{"exercise_price":1.27,"underlying":"Class A common stock","underlying_shares":159744},"source":{"system":"sec-edgar","filing":"0001437749-23-028074","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000143774923028074/rdgdoc.xml","form_type":"4"}},{"id":1844347,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":109067,"kind":"person","name":"Powchik Peter","position":1,"cik":"0001377247","reported_name":"Powchik Peter","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2023-06-26T18:31:14.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":132352,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These options were automatically granted following the Issuer's annual shareholders meeting pursuant to a policy adopted by the Issuer's board of directors providing for annual non-employee director compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vest on the earliest of (i) the one-year anniversary of the grant date, (ii) the following year's annual stockholder meeting, and (iii) a Change in Control (as defined in the Vaxxinity, Inc. 2021 Omnibus Incentive Compensation Plan), in each case, subject to the Reporting Person's continued service with the Issuer through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These stock options shall expire upon the earlier of (i) the tenth anniversary of the grant date, and (ii) three months after the date the Reporting Person ceases to be a director, officer, employee or consultant of the Issuer or one of its affiliates."}],"balance_after":132352,"derivative":{"exercise_price":2.21,"underlying":"Class A Common Stock","underlying_shares":132352},"source":{"system":"sec-edgar","filing":"0001437749-23-018534","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000143774923018534/rdgdoc.xml","form_type":"4"}},{"id":2223157,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":109067,"kind":"person","name":"Powchik Peter","position":1,"cik":"0001377247","reported_name":"Powchik Peter","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2022-06-23T19:54:51.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":129187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"These options were automatically granted following the Issuer's annual shareholders meeting pursuant to a policy adopted by the Issuer's board of directors providing for annual non-employee director compensation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vest on the earliest of (i) the one-year anniversary of the grant date, (ii) the following year's annual stockholder meeting, and (iii) a Change in Control (as defined in the Vaxxinity, Inc. 2021 Omnibus Incentive Compensation Plan), in each case, subject to the Reporting Person's continued service with the issuer through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These stock options shall expire upon the earlier of (i) the tenth anniversary of the grant date, and (ii) three months after the date the Reporting Person ceases to be a director, officer, employee or consultant of the Issuer or one of its affiliates."}],"balance_after":129187,"derivative":{"exercise_price":2.09,"underlying":"Class A common stock","underlying_shares":129187},"source":{"system":"sec-edgar","filing":"0001437749-22-015778","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000143774922015778/rdgdoc.xml","form_type":"4"}},{"id":2308708,"issuer":{"id":91688,"kind":"organization","name":"Vaxxinity, Inc.","symbol":"VAXX"},"owners":[{"id":109067,"kind":"person","name":"Powchik Peter","position":1,"cik":"0001377247","reported_name":"Powchik Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-04-04T19:55:37.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":94186,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are subject to a three-year time-vesting schedule, with 31,395 shares vesting on the first and second anniversaries of the grant date and the remainder vesting on the third anniversary of the grant date."}],"balance_after":94186,"derivative":{"exercise_price":4.3,"expiration_date":"2022-03-31","underlying":"Class A common stock","underlying_shares":94186},"source":{"system":"sec-edgar","filing":"0000899243-22-013482","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851657/000089924322013482/doc4.xml","form_type":"4"}},{"id":4517636,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":109067,"kind":"person","name":"Powchik Peter","position":1,"cik":"0001377247","reported_name":"Powchik Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Clinical Development & Reg"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-12-19T21:15:06.000Z","date":"2016-12-16","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option award vests in full one year after the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":381.92,"expiration_date":"2026-12-16","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001237899-16-000089","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789916000089/edgardoc.xml","form_type":"4"}},{"id":4517635,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":109067,"kind":"person","name":"Powchik Peter","position":1,"cik":"0001377247","reported_name":"Powchik Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Clinical Development & Reg"}}],"security":"Common Stock","published_at":"2016-12-19T21:15:06.000Z","date":"2016-05-16","kind":"gift","acquired":true,"shares":2459,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by trust for daughte"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By a trust for the benefit of the reporting person's daughter of which the reporting person's spouse is trustee."}],"balance_after":2459,"source":{"system":"sec-edgar","filing":"0001237899-16-000089","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789916000089/edgardoc.xml","form_type":"4"}},{"id":4517634,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":109067,"kind":"person","name":"Powchik Peter","position":1,"cik":"0001377247","reported_name":"Powchik Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Clinical Development & Reg"}}],"security":"Common Stock","published_at":"2016-12-19T21:15:06.000Z","date":"2016-05-16","kind":"gift","acquired":true,"shares":2459,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Trust for Son"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"By a trust for the benefit of the reporting person's son of which the reporting person's spouse is trustee."}],"balance_after":2459,"source":{"system":"sec-edgar","filing":"0001237899-16-000089","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789916000089/edgardoc.xml","form_type":"4"}},{"id":4517633,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":109067,"kind":"person","name":"Powchik Peter","position":1,"cik":"0001377247","reported_name":"Powchik Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Clinical Development & Reg"}}],"security":"Common Stock","published_at":"2016-12-19T21:15:06.000Z","date":"2016-05-16","kind":"gift","acquired":false,"shares":2459,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by GRAT"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001237899-16-000089","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789916000089/edgardoc.xml","form_type":"4"}},{"id":4517632,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":109067,"kind":"person","name":"Powchik Peter","position":1,"cik":"0001377247","reported_name":"Powchik Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Clinical Development & Reg"}}],"security":"Common Stock","published_at":"2016-12-19T21:15:06.000Z","date":"2016-05-16","kind":"gift","acquired":false,"shares":2459,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by GRAT"},"balance_after":2459,"source":{"system":"sec-edgar","filing":"0001237899-16-000089","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789916000089/edgardoc.xml","form_type":"4"}}]}